{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:29:17Z","timestamp":1791635357314,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Kinase-catalyzed phosphorylation plays a crucial role in pathological cardiac hypertrophy. Here, we show that CDC-like kinase 4 (CLK4) is a critical regulator of cardiomyocyte hypertrophy and heart failure. Knockdown of\n                    <jats:italic>Clk4<\/jats:italic>\n                    leads to pathological cardiomyocyte hypertrophy, while overexpression of\n                    <jats:italic>Clk4<\/jats:italic>\n                    confers resistance to phenylephrine-induced cardiomyocyte hypertrophy. Cardiac-specific\n                    <jats:italic>Clk4<\/jats:italic>\n                    -knockout mice manifest pathological myocardial hypertrophy with progressive left ventricular systolic dysfunction and heart dilation. Further investigation identifies nexilin (NEXN) as the direct substrate of CLK4, and overexpression of a phosphorylation-mimic mutant of NEXN is sufficient to reverse the hypertrophic growth of cardiomyocytes induced by\n                    <jats:italic>Clk4<\/jats:italic>\n                    knockdown. Importantly, restoring phosphorylation of NEXN ameliorates myocardial hypertrophy in mice with cardiac-specific\n                    <jats:italic>Clk4<\/jats:italic>\n                    deletion. We conclude that CLK4 regulates cardiac function through phosphorylation of NEXN, and its deficiency may lead to pathological cardiac hypertrophy. CLK4 is a potential intervention target for the prevention and treatment of heart failure.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-31996-9","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T09:04:13Z","timestamp":1659171853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["CDC-like kinase 4 deficiency contributes to pathological cardiac hypertrophy by modulating NEXN phosphorylation"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-1305","authenticated-orcid":false,"given":"Jian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunli","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0524-7515","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-8396","authenticated-orcid":false,"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-1835","authenticated-orcid":false,"given":"Yi-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"31996_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387\u2013407 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"31996_CR2","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","volume":"122","author":"I Kehat","year":"2010","unstructured":"Kehat, I. & Molkentin, J. D. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122, 2727\u20132735 (2010).","journal-title":"Circulation"},{"key":"31996_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1006\/geno.2000.6447","volume":"71","author":"J Schultz","year":"2001","unstructured":"Schultz, J. et al. Molecular characterization of a cDNA encoding functional human CLK4 kinase and localization to chromosome 5q35 [correction of 4q35]. Genomics 71, 368\u2013370 (2001).","journal-title":"Genomics"},{"key":"31996_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1042\/bj3260693","volume":"326","author":"O Nayler","year":"1997","unstructured":"Nayler, O., Stamm, S. & Ullrich, A. Characterization and comparison of four serine- and arginine-rich (SR) protein kinases. Biochem. J 326, 693\u2013700 (1997).","journal-title":"Biochem. J"},{"key":"31996_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1158\/0008-5472.CAN-14-2443","volume":"75","author":"T Yoshida","year":"2015","unstructured":"Yoshida, T. et al. CLK2 is an oncogenic kinase and splicing regulator in breast cancer. Cancer Res. 75, 1516\u20131526 (2015).","journal-title":"Cancer Res."},{"key":"31996_CR6","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1093\/nar\/gkt170","volume":"41","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion. Nucleic Acids Res. 41, 4949\u20134962 (2013).","journal-title":"Nucleic Acids Res."},{"key":"31996_CR7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature08760","volume":"463","author":"A Karlas","year":"2010","unstructured":"Karlas, A. et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463, 818\u2013822 (2010).","journal-title":"Nature"},{"key":"31996_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cmet.2009.11.006","volume":"11","author":"JT Rodgers","year":"2010","unstructured":"Rodgers, J. T., Haas, W., Gygi, S. P. & Puigserver, P. Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic gluconeogenesis. Cell Metab. 11, 23\u201334 (2010).","journal-title":"Cell Metab."},{"key":"31996_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11451","volume":"7","author":"E Petsalaki","year":"2016","unstructured":"Petsalaki, E. & Zachos, G. Clks 1, 2 and 4 prevent chromatin breakage by regulating the Aurora B-dependent abscission checkpoint. Nat. Commun. 7, 1\u201313 (2016).","journal-title":"Nat. Commun."},{"key":"31996_CR10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0968-0004(00)01712-6","volume":"25","author":"P Cohen","year":"2000","unstructured":"Cohen, P. The regulation of protein function by multisite phosphorylation\u2013a 25 year update. Trends Biochem. Sci. 25, 596\u2013601 (2000).","journal-title":"Trends Biochem. Sci."},{"key":"31996_CR11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.str.2011.09.021","volume":"19","author":"H Nishi","year":"2011","unstructured":"Nishi, H., Hashimoto, K. & Panchenko, A. R. Phosphorylation in protein-protein binding: effect on stability and function. Structure 19, 1807\u20131815 (2011).","journal-title":"Structure"},{"key":"31996_CR12","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1083\/jcb.143.5.1227","volume":"143","author":"T Ohtsuka","year":"1998","unstructured":"Ohtsuka, T. et al. Nexilin: a novel actin filament-binding protein localized at cell\u2013matrix adherens junction[J]. J. Cell Biol. 143, 1227\u20131238 (1998).","journal-title":"J. Cell Biol."},{"key":"31996_CR13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/nm.2037","volume":"15","author":"D Hassel","year":"2009","unstructured":"Hassel, D. et al. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat. Med. 15, 1281\u20131288 (2009).","journal-title":"Nat. Med."},{"key":"31996_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ajhg.2010.10.002","volume":"87","author":"H Wang","year":"2010","unstructured":"Wang, H. et al. Mutations in NEXN, a Z-disc gene, are associated with hypertrophic cardiomyopathy. Am. J. Hum. Genet. 87, 687\u2013693 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"31996_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/BJ20081501","volume":"417","author":"JC Long","year":"2009","unstructured":"Long, J. C. & Caceres, J. F. The SR protein family of splicing factors: master regulators of gene expression. Biochem. J. 417, 15\u201327 (2009).","journal-title":"Biochem. J."},{"key":"31996_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1006\/excr.1998.4083","volume":"241","author":"PI Duncan","year":"1998","unstructured":"Duncan, P. I., Stojdl, D. F., Marius, R. M., Scheit, K. H. & Bell, J. C. The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing. Exp. Cell Res. 241, 300\u2013308 (1998).","journal-title":"Exp. Cell Res."},{"key":"31996_CR17","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1128\/MCB.17.10.5996","volume":"17","author":"PI Duncan","year":"1997","unstructured":"Duncan, P. I., Stojdl, D. F., Marius, R. M. & Bell, J. C. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase. Mol. Cell Biol. 17, 5996\u20136001 (1997).","journal-title":"Mol. Cell Biol."},{"key":"31996_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0079-6603(01)70013-X","volume":"70","author":"TE Roche","year":"2001","unstructured":"Roche, T. E. et al. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog. Nucleic Acid Res. Mol. Biol 70, 33\u201375 (2001).","journal-title":"Prog. Nucleic Acid Res. Mol. Biol"},{"key":"31996_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/bj3580069","volume":"358","author":"E Kolobova","year":"2001","unstructured":"Kolobova, E., Tuganova, A., Boulatnikov, I. & Popov, K. M. Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites. Biochem. J. 358, 69\u201377 (2001).","journal-title":"Biochem. J."},{"key":"31996_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BFb0031008","volume":"96","author":"OH Wieland","year":"1983","unstructured":"Wieland, O. H. The mammalian pyruvate dehydrogenase complex: structure and regulation. Rev. Physiol. Biochem. Pharmacol 96, 123\u2013170 (1983).","journal-title":"Rev. Physiol. Biochem. Pharmacol"},{"key":"31996_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCULATIONAHA.119.039751","volume":"140","author":"C Liu","year":"2019","unstructured":"Liu, C. et al. Nexilin is a new component of junctional membrane complexes required for cardiac t-tubule formation. Circulation 140, 55\u201366 (2019).","journal-title":"Circulation"},{"key":"31996_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms6177","volume":"5","author":"J Li","year":"2014","unstructured":"Li, J. et al. SNX13 reduction mediates heart failure through degradative sorting of apoptosis repressor with caspase recruitment domain. Nat. Commun. 5, 1\u201313 (2014).","journal-title":"Nat. Commun."},{"key":"31996_CR23","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang, S. et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat. Med. 18, 1639\u20131642 (2012).","journal-title":"Nat. Med."},{"key":"31996_CR24","first-page":"1459","volume":"6","author":"K Bersell","year":"2013","unstructured":"Bersell, K. et al. Moderate and high amounts of tamoxifen in alphaMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis. Model. Mech. 6, 1459\u20131469 (2013).","journal-title":"Dis. Model. Mech."},{"key":"31996_CR25","doi-asserted-by":"crossref","unstructured":"Zaw, A. M., Williams, C. M., Law, H. K. & Chow, B. K. Minimally invasive transverse aortic constriction in mice. J. Vis. Exp. e55293 (2017).","DOI":"10.3791\/55293"},{"key":"31996_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.biopha.2017.06.002","volume":"93","author":"X Li","year":"2017","unstructured":"Li, X., Zhang, Z. L. & Wang, H. F. Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-beta1\/SMADs and PI3K\/AKT signaling pathways. Biomed. Pharmacother. 93, 130\u2013145 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"31996_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07858-8","volume":"10","author":"HV Woodcock","year":"2019","unstructured":"Woodcock, H. V. et al. The mTORC1\/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat. Commun. 10, 1\u201316 (2019).","journal-title":"Nat. Commun."},{"key":"31996_CR28","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1172\/JCI42028","volume":"120","author":"P Teekakirikul","year":"2010","unstructured":"Teekakirikul, P. et al. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta. J. Clin. Invest. 120, 3520\u20133529 (2010).","journal-title":"J. Clin. Invest."},{"key":"31996_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-62703-360-2_8","volume":"1002","author":"LR Yu","year":"2013","unstructured":"Yu, L. R. & Veenstra, T. Phosphopeptide enrichment using offline titanium dioxide columns for phosphoproteomics. Methods Mol. Biol. 1002, 93\u2013103 (2013).","journal-title":"Methods Mol. Biol."},{"key":"31996_CR30","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41556-019-0380-8","volume":"21","author":"M Zhang","year":"2019","unstructured":"Zhang, M. et al. CaMKII-delta9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair. Nat. Cell Biol. 21, 1152\u20131163 (2019).","journal-title":"Nat. Cell Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31996-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31996-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31996-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:22:55Z","timestamp":1669296175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31996-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31996"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31996-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4433"}}